Literature DB >> 19903915

Polymyxin B hemoperfusion and mortality in abdominal septic shock.

Jean-Louis Vincent.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903915     DOI: 10.1001/jama.2009.1606

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Clinical trial report-polymyxin B hemoperfusion: effective, or not?

Authors:  Jean-Louis Vincent
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

2.  The Japanese guidelines for the management of sepsis.

Authors:  Shigeto Oda; Mayuki Aibiki; Toshiaki Ikeda; Hitoshi Imaizumi; Shigeatsu Endo; Ryoichi Ochiai; Joji Kotani; Nobuaki Shime; Osamu Nishida; Takayuki Noguchi; Naoyuki Matsuda; Hiroyuki Hirasawa
Journal:  J Intensive Care       Date:  2014-10-28

3.  Treatment with a polymyxin B filter to capture endotoxin in sepsis patients: is there a signal for therapeutic efficacy?

Authors:  Peter Pickkers; James A Russell
Journal:  Intensive Care Med       Date:  2018-12-03       Impact factor: 17.440

4.  Analysis of the efficacy of direct hemoperfusion with polymyxin B-immobilized fiber (PMX-DHP) according to the prognostic factors in patients with colorectal perforation.

Authors:  Kiichi Sugimoto; Koichi Sato; Hiroshi Maekawa; Mutsumi Sakurada; Hajime Orita; Tomoaki Ito; Kazuhiro Sakamoto
Journal:  Surg Today       Date:  2012-11-06       Impact factor: 2.549

Review 5.  Direct hemoperfusion with polymyxin B immobilized fiber for abdominal sepsis in Europe.

Authors:  Koichi Sato; Hiroshi Maekawa; Mutsumi Sakurada; Hajime Orita; Yoshihiro Komatsu
Journal:  Surg Today       Date:  2011-06       Impact factor: 2.549

6.  What's new in the extracorporeal treatment of sepsis?

Authors:  Peter Pickkers; Didier Payen
Journal:  Intensive Care Med       Date:  2017-03-17       Impact factor: 17.440

Review 7.  The Rationale and Current Status of Endotoxin Adsorption in the Treatment of Septic Shock.

Authors:  Jakub Śmiechowicz
Journal:  J Clin Med       Date:  2022-01-26       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.